HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chikuma, S. Articles by Bluestone, J. A. Search for Related Content PubMed PubMed Citation Articles by Chikuma, S. Articles by Bluestone, J. A.

CTLA-4: Acting at the Synapse

University of California at San Francisco Diabetes Center, San Francisco, CA 94143-0540

SUMMARY

Egen and Allison have reported that cytotoxic T lymphocyte antigen-4 (CTLA-4), an immune-response–inhibiting protein, accumulates in a two-step process at immune synapses (the sites of physical contact between T cells and antigen-presenting cells). Depending upon the strength of the signal through the T cell receptor (TCR), CTLA-4 may reside at a cytoplasmic location near the synapse (in instances of weaker stimulation) or localize to the synapse itself (under strong TCR signaling conditions). Chikuma and Bluestone discuss these findings and how CTLA-4 might inhibit T cell activation, either by increasing the threshold for activation, or by dampening existing immune responses. These findings also have important ramifications for autoimmunity and the breadth of T cell proliferation (diverse vs. narrow clonal expansion) in immune responses.

This article has been cited by other articles:

				G. C. Zeller, J. Hirahashi, A. Schwarting, A. H. Sharpe, and V. R. Kelley Inducible Co-Stimulator Null MRL-Faslpr Mice: Uncoupling of Autoantibodies and T Cell Responses in Lupus J. Am. Soc. Nephrol., January 1, 2006; 17(1): 122 - 130. [Abstract] [Full Text] [PDF]